Often when a patient walks into a provider's office, he or she might not have any idea about the total cost of the visit-except what the copay might be.
Often when a patient walks into a provider's office, he or she might not have any idea about the total cost of the visit-except what the copay might be.
"In today's world there is a lot of confusion related to consumers understanding their obligation, in that they do not pay for their out-of-pocket costs in a consistent, timely or an efficient manner," says Bill Fandrich, HealthePass Product Executive, for Bloomfield, Conn.-based CIGNA Healthcare. He projects that patients' payments to providers will more than double in the next five years. "The healthcare payment process still operates under the traditional managed-care model, which is a copay patient obligation model that does not effectively address deductible and co-insurance payment obligation," he adds.
To fulfill that need, CIGNA plans to launch its HealthePass solution in 2007 with some of the largest hospital systems and physician groups in the United States. At its core, HealthePass consists of a robust, comprehensive cost calculator that will supply accurate, personalized estimates of patient liability and is intended to be an easily adopted tool for providers that will clearly set financial expectations, shorten providers' revenue cycles and significantly reduce the potential for patient bad debt.
PROVIDER PERSPECTIVE
HealthePass is the product of a thorough reassessment of the healthcare marketplace by CIGNA. While many in the industry might have explored real-time claims adjudication and debit cards, CIGNA also sought input from providers, physician groups, hospitals, employers and others to see the industry from a provider's perspective, according to Fandrich.
"We took a step back and did several months of detailed market analysis, including hundreds of hours of interviews with providers," Fandrich says. "As a byproduct of that, we saw the need to introduce a different kind of solution, one that could work across the various provider business models. We needed to provide a solution that could cross products-PPO plans, consumer-directed plans and other plans with a wide variety of benefit options. We needed to provide a very simple way for both the consumer and provider to understand the patient's financial obligation."
Significant among its multiple functions, HealthePass ensures there is a shared understanding of the patient obligation during the healthcare delivery cycle-before, during or after treatment. Whereas most cost calculators today use the "charge" information to make non-specific cost estimates, HealthePass's calculator generates an estimate based on the specific treatment, provider contract, and a real-time snapshot of the patient's covered benefits.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Air Pollution May Negatively Affect Male Reproductive Health
November 30th 2023A potential mechanism by which air pollutants may affect reproductive health is by endocrine disruption. Air pollutants are made up of mixtures of particulate matter that may include endocrine disruptors, such as polycyclic aromatic hydrocarbons (PAHs) and heavy metals.
Read More
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More